Kerry Hege

Rivaroxaban compared with standard anticoagulants for the treatment of acute venous thromboembolism in children: a randomised, controlled, phase 3 trial

Christoph Male, Anthonie W.A. Lensing, Joseph S. Palumbo et al. · The Lancet Haematology · 2019 · 315 citations · Full text

Medicine, Pediatrics, Pharmacotherapy +13

Safety and efficacy of rivaroxaban in pediatric cerebral venous thrombosis (EINSTEIN-Jr CVT)

Philip Connor, Mayte Sánchez van Kammen, Anthonie W.A. Lensing et al. · Blood Advances · 2020 · 114 citations · Full text

Medicine, Pediatrics, Pharmacotherapy +17

Effect of Anticoagulant Therapy for 6 Weeks vs 3 Months on Recurrence and Bleeding Events in Patients Younger Than 21 Years of Age With Provoked Venous Thromboembolism

Neil A. Goldenberg, John M. Kittelson, Thomas C. Abshire et al. · JAMA · 2022 · 94 citations · Full text

Medicine, Hematology, Internal Medicine +17

Rivaroxaban for treatment of pediatric venous thromboembolism. An Einstein‐Jr phase 3 dose‐exposure‐response evaluation

Guy Young, Anthonie W.A. Lensing, Paul Monagle et al. · Journal of Thrombosis and Haemostasis · 2020 · 85 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

Second‐line treatments in children with immune thrombocytopenia: Effect on platelet count and patient‐centered outcomes

Rachael F. Grace, Kristin A. Shimano, Rukhmi Bhat et al. · American Journal of Hematology · 2019 · 52 citations · Full text

Medicine, Hematology, Pediatrics +13